TABLE 1.
Group characteristics | Hyperlipidemic | Normolipidemic | P value |
---|---|---|---|
Total number, n | 16 | 28 | — |
Patients characteristics | |||
Age (y), median (range) | 8.5 (6.7‐11.9) | 9.1 (7.1‐12.2) | .57 |
Sex, male/female (neutered) | 5 (5)/11 (11) | 14 (8)/14 (5) | .34 |
Body weight (kg), median (range) | 8.36 (5‐10.88) | 7.37 (5.44‐10.7) | .03 |
BCS, median | 5 | 5 | |
BCS category, n (%) | .13 | ||
≤5 | 14 (87.5%) | 28 (100%) | |
>5 | 2 (12.5%) | 0 (0%) | |
Clinicopathologic variables (RI), median (range) | |||
Serum triglyceride (26‐108 mg/dL) | 480 (181‐1320) | 54 (19‐108) | <.001 |
Serum cholesterol (124‐335 mg/dL) | 362.6 (158‐575) | 168.4 (121.7‐316.1) | <.001 |
Serum total T4 (1.61‐3.6 μg/dL) | 2.3 (1.2‐5.05) | 1.785 (0.5‐5.28) | .52 |
Serum cTSH (≤0.6 ng/mL) | 0.235 (0.09‐1.24) | 0.203 (0.029‐0.86) | .74 |
Serum free T4 (0.7‐3.1 ng/dL) | 1.35 (0.6‐4.0) | 1.5 (0.4‐2.5) | .62 |
Serum Spec cPL (0‐200 μg/L) | 93 (29‐473) | 29 (12‐386) | .32 |
Serum glucose (60‐120 mg/dL) | 104 (79‐131) | 98 (51‐125) | 1 |
Note: Bold face values indicate statistical significance at P < .05.
Abbreviations: BCS, body condition score (range of possible scores: 1‐9); cTSH, canine thyroid‐stimulating hormone; RI, reference interval; Spec cPL, specific canine pancreatic lipase.